A cohort of 47 patients is screened for pancreatic cancer precursors with a portable 96‐well
bioelectronic sensing‐array for single‐molecule assay in cysts fluid and blood plasma, …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and estimated
to become the second leading cause of cancer-related deaths by 2030. Although overall 5-…

Defects in transcriptional regulators of pancreatic exocrine differentiation have been implicated
in pancreatic tumorigenesis, but the molecular mechanisms are poorly understood. The …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive neoplasm
with a poor survival rate. This is mainly due to late detection, which substantially limits …

Objective Due to the limited number of modifiable risk factors, secondary prevention
strategies based on early diagnosis represent the preferred route to improve the prognosis of …

Background Chronic pancreatitis is a complex multifactorial fibro-inflammatory disease.
Consensus guidelines are needed for the histopathological evaluation of non-autoimmune …

Simple Summary To elucidate and compare the value of plasma and bile as liquid biopsy
source, cfDNA from 80 patients with pancreatobiliary cancers or non-malignant biliary …

Background/objectives An abundant stromal reaction is a hallmark of pancreatic ductal
adenocarcinoma (PDAC) and chronic pancreatitis (CP). The cells mainly responsible for the …

Pancreatic cystic lesions (PCL) are increasingly diagnosed. Endoscopic ultrasound fine-needle
aspiration (EUS-FNA) cytology is often used for diagnostic confirmation but can be …

Background Para-aortic lymph nodes in the ductal adenocarcinoma of the pancreatic head
are regarded as distant metastases. Chemotherapy is considered the only treatment option if …